Anti-ZIKV Neutralizing Antibody (V3S-0723-FY192) (CAT#: V3S-0723-FY192)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Sub Cat Isotype Affinity  
V3S-1124-YC569 IgG1 Inquiry
V3S-0723-FY193 IgG Inquiry
V3S-0723-FY194 IgG1 kappa Inquiry
V3S-0723-FY195 IgG1 kappa Inquiry
V3S-0723-FY196 IgG 47 nM Inquiry
Summary
Property
Applications
Protocols
Target

Summary

Description The antibody was bound to ZIKV and neutralized the virus. The antibody is specific for ZIKV and does not cross react with DENV. Furthermore, plasma from ZIKV-positive individuals blocked the interaction of the mAb with ZIKV, whereas plasma from DENV-positive patients did not. This antibody targets immunodominant loci, as ZIKV-positive samples block P1F12-ZIKV binding.
Clonality Monoclonal
Host Species Human
Target Species Zika Virus (ZIKV)
Isotype IgG1

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein A purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics.

Applications

Application ELISA; WB; Neut

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target ZIKV
Alternative Name Zika virus; ZIKV
Research Area Microbiology
For research use only, not directly for clinical use.
banner banner
© 2025 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry